Bruehlman Ronald E 4
4 · GoodRx Holdings, Inc. · Filed Nov 10, 2025
Insider Transaction Report
Form 4
Bruehlman Ronald E
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-08+21,691→ 111,025 total - Exercise/Conversion
Deferred Stock Unit
2025-11-08−21,691→ 43,384 total→ Class A Common Stock (21,691 underlying)
Footnotes (2)
- [F1]The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
- [F2]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.